surmount-1 tirzepatide trial obesity without diabetes SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, tirzepatide trial obesity without diabetes
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1




00377-2/asset/5849e908-c26a-472e-b460-1c99904b95c5/main.assets/gr2.jpg)





















